Past performance is no guarantee of future returns.
Had you invested
₹
Over the last
1Y
3Y
ALL
Your returns would have been
Nippon India Pharma (G)
₹1,00,00,00,000
14.0%
Fixed deposit
₹40,00,00,000
6.0%
Bank savings
₹40,00,00,000
3.0%
See fund holdings as of 31st Mar
Top holdings
Sun Pharmaceuticals Industries Ltd
14.9%
Lupin Ltd
8.4%
Cipla Ltd
6.5%
Apollo Hospitals Enterprise Ltd
5.8%
Dr Reddy's Laboratories Ltd
4.8%
Gland Pharma Ltd
4.4%
Divi's Laboratories Ltd
4.4%
Zydus Lifesciences Ltd
4.2%
J.B. Chemicals & Pharmaceuticals Ltd
3.4%
Abbott India Ltd
3.3%
Top industry exposure
Healthcare
97.2%
Other information
Minimum SIP
₹100
Minimum lumpsum
₹5,000
Additional lumpsum
₹1,000
Portfolio turnover
16%
Lock-in period
-
Exit load
• 1% for redemption within 30 days
Fund objective
The primary investment objective of the scheme is to seek to generate consistent returns by investing in equity and equity related or fixed income securities of Pharma and other associated companies.